Arne Freundt took over as Puma CEO effective immediately to replace Bjorn Gulden who relinquished the post to head rival Adidas.
Puma’s appointment of Freundt as chief executive with immediate effect on Tuesday came several weeks before it was initially announced.
Freundt, according to Puma, is receiving a four-year contract effective from January 1 of 2023. Gulden’s mandate as a Puma SE Management Board member expires at the end of 2022.
Héloïse Temple-Boyer, Chair of the Supervisory Board of Puma, called Freundt the ideal choice to continue Puma’s very successful path and to further accelerate the company’s momentum.
Freundt has held various positions for Puma for over ten years and was responsible for framing corporate strategy, taking care of the Global Direct-to-Consumer business, and the Region EMEA as a General Manager.
He has also been a member of the Management Board as Chief Commercial Officer since June 2021.


Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
Nvidia Beats Earnings Expectations as AI Demand Drives Record Growth
Native American Groups Slam Trump’s Call to Restore Redskins Name
Trump to Host UFC Event at White House on His 80th Birthday
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission
Australia Regulator Flags Private Credit Risks Amid Global Market Uncertainty
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
US Stock Futures Slip as Nvidia Earnings Fail to Fully Impress Investors
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
U.S. Plans $115 Million Counter-Drone Investment to Secure FIFA World Cup and Major National Events
Gold Prices Climb as Trump Delays Iran Strike, Boosting Safe-Haven Demand
Oil Tankers Exit Strait of Hormuz as Trump Signals Possible Iran Deal
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness 



